Related references
Note: Only part of the references are listed.Biliary stone disease in patients receiving somatostatin analogs for neuroendocrine neoplasms. A retrospective observational study
Nicole Brighi et al.
DIGESTIVE AND LIVER DISEASE (2019)
Management of gallstones and its related complications
P. Portincasa et al.
EXPERT REVIEW OF GASTROENTEROLOGY & HEPATOLOGY (2016)
Risk Factors for Cholelithiasis
Mila Pak et al.
GASTROENTEROLOGY NURSING (2016)
EASL Clinical Practice Guidelines on the prevention, diagnosis and treatment of gallstones
JOURNAL OF HEPATOLOGY (2016)
Determinants for gallstone formation - a new data cohort study and a systematic review with meta-analysis*
Daniel Monsted Shabanzadeh et al.
SCANDINAVIAN JOURNAL OF GASTROENTEROLOGY (2016)
Gallstones
Frank Lammert et al.
NATURE REVIEWS DISEASE PRIMERS (2016)
Adverse events associated with somatostatin analogs in acromegaly
Ludovica F. S. Grasso et al.
EXPERT OPINION ON DRUG SAFETY (2015)
Obesity and the risk and prognosis of gallstone disease and pancreatitis
Leonilde Bonfrate et al.
BEST PRACTICE & RESEARCH CLINICAL GASTROENTEROLOGY (2014)
Acromegaly: An Endocrine Society Clinical Practice Guideline
Laurence Katznelson et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2014)
Pasireotide Versus Octreotide in Acromegaly: A Head-to-Head Superiority Study
A. Colao et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2014)
Pasireotide versus continued treatment with octreotide or lanreotide in patients with inadequately controlled acromegaly (PAOLA): a randomised, phase 3 trial
Monica R. Gadelha et al.
LANCET DIABETES & ENDOCRINOLOGY (2014)
Ursodeoxycholic acid therapy in gallbladder disease, a story not yet completed
Michele Pier Luca Guarino et al.
WORLD JOURNAL OF GASTROENTEROLOGY (2013)
Cholelithiasis and acromegaly: therapeutic strategies
M. Montini et al.
CLINICAL ENDOCRINOLOGY (2010)
Octreotide LAR: safety and tolerability issues
Jan Bornschein et al.
EXPERT OPINION ON DRUG SAFETY (2009)
Somatostatin analogs and gallstones: A retrospective survey on a large series of acromegalic patients
R. Attanasio et al.
JOURNAL OF ENDOCRINOLOGICAL INVESTIGATION (2008)
Microlithiasis and sludge
Christoph Juengst et al.
BEST PRACTICE & RESEARCH CLINICAL GASTROENTEROLOGY (2006)
Biliary sludge is formed by modification of hepatic bile by the gallbladder mucosa
CW Ko et al.
CLINICAL GASTROENTEROLOGY AND HEPATOLOGY (2005)
Octreotide induced prolongation of colonic transit increases faecal anaerobic bacteria, bile acid metabolising enzymes, and serum deoxycholic acid in patients with acromegaly
LA Thomas et al.
GUT (2005)
Genetic and environmental influences on symptomatic gallstone disease: a Swedish study of 43,141 twin pairs
D Katsika et al.
HEPATOLOGY (2005)
Severe impairment of postprandial cholecystokinin release and gall-bladder emptying and high risk of gallstone formation in acromegalic patients during Sandostatin LAR
A Moschetta et al.
ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2001)
Share Paper
